Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 5:9:155-158.
doi: 10.33393/grhta.2022.2495. eCollection 2022 Jan-Dec.

La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti

[Article in Italian]
Anna Maria Marata  1 , Walter Marrocco  2 , Emanuela Arcangeli  3 , Mattia Battistini  4 , Giuliano Buzzetti  5 , Riccardo Candido  6 , Gianluigi Casadei  7 , Francesco Cattel  8 , Arturo Cavaliere  9 , Agostino Consoli  10 , Giovanni Corrao  11 , Guido Didoni  12 , Mauro Di Gesù  4 , Alberto Giovanzana  13 , Matteo Lenzi  14 , Massimo Medaglia  5 , Marta Meloncelli  15 , Stefano Palcic  6 , Marcello Pani  16 , Francesca Patarnello  17 , Emanuele Pria  18 , Dario Scaduto  19 , Valeria Tozzi  20 , Marco Zibellini  21 , Elisa Crovato  22
Affiliations

La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti

[Article in Italian]
Anna Maria Marata et al. Glob Reg Health Technol Assess. .

Abstract

This document illustrates the results of the work of two interdisciplinary and multistakeholder panels (researchers, public institutions, and industry representatives) on drug territorialization and digitalization, organized as part of a residential seminar held on 30 September and 1st October 2021.

Arising from some considerations about the demand for health and the provisions of the National Recovery and Resilience Plan (PNRR), the discussion touched various aspects of managing the transition from current to future management models. The importance of identifying criteria for prioritizing interventions in the area emerged: different methods of drug delivery, scientific information and measurement, re-evaluation of pathologies that can be managed in this area. Finally, the role of digitization within this change was explored.

The opinions provided by the experts move towards making the most of the opportunities arising from PNRR, in terms of investments in healthcare and data application, with a view to improve health system efficiency, patient care and related outcomes.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The Authors declare no potential conflict of interest with respect to the research, authorship and/or publication of this article. The authors declare the following competing interests: AMM, FC, GCo, AG, ML, MMed , MMel, SP, MP, FP, MZ declare no conflict of interest. WM reports holding a fiduciary role in FIMMG, EPCCS and Consulta. EA is an employee of Amgen and reports stock ownership in the company. MB is an employee of Sanofi. GB is an employee of Dephaforum. RC reported receiving consulting fees from MSD Italia, Eli Lilly Italy, Menarini Diagnostics, Roche Diabetes Care Italy, honoraria from Novo Nordisk, Sanofi, Abbott, Mundipharma Farmaceuticals, participation to an advisory boards supported by Boehringer Ingelheim. GCa reported receiving consulting fees from Novartis, Alexion, AstraZeneca, Abbvie, Astellas, Roche, Takeda, Jannsen and Biomarin. ACa reported receiving consulting fees from MSD Italia, Eli Lilly Italy, Menarini Diagnostics, Roche Diabetes Care Italy, honoraria from Novo Nordisk, Sanofi, Abbott, Mundipharma Farmaceuticals, participation to advisory boards supported by Boehringer Ingelheim. ACo reported receiving research grants by AstraZeneca, honoraria from Novo Nordisk, Eli Lilly, Merck Sharp & Dhome, participation on advisory boards supported by Novo Nordisk and Eli Lilly. GD reports stock ownership in Bristol Meyers Squibb. MDG is an employee of Sanofi and reports stock ownership in the company. EP is an employee or Gilead Sciences and reports stock ownership in the company. DS is an employee of Abbvie. VT reported receiving consulting fees from Biogen Italia and grants from FEEM Fondazione Eni Enrico Mattei. EC is an employee of Chiesi Italia.

References

    1. Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Harvard Business School Press; 2006. [Accessed September; 2022 ]. Online
    1. Porter ME. Value-based health care delivery. Ann Surg. 2008;248(4):503–509. doi: 10.1097/SLA.0b013e31818a43af. - DOI - PubMed
    1. Corrao G, Alquati G, Apolone G et al. Real-world data: how they can help to improve quality of care. Glob Reg Health Technol Assess. 2021;8:134–139. doi: 10.33393/grhta.2021.2286. - DOI - PMC - PubMed

LinkOut - more resources